citalopram has been researched along with Liver Cirrhosis in 3 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the pharmacokinetics of the antidepressant citalopram and its metabolites demethylcitalopram and didemethylcitalopram in subjects with moderate renal insufficiency and subjects with hepatic cirrhosis with that in healthy subjects." | 9.08 | Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects. ( Aaes-Jørgensen, T; Joffe, P; Larsen, FS; Pedersen, V; Ring-Larsen, H; Sidhu, J, 1998) |
| "Side effects such as myoclonus and tremor are rare when treating with selective serotonin reuptake inhibitors (SSRIs)." | 5.42 | [Myoclonus as a side effect to citalopram treatment in a patient with liver cirrhosis]. ( Bode, M; Forsberg-Gillving, M; Sindrup, SH, 2015) |
| "To compare the pharmacokinetics of the antidepressant citalopram and its metabolites demethylcitalopram and didemethylcitalopram in subjects with moderate renal insufficiency and subjects with hepatic cirrhosis with that in healthy subjects." | 5.08 | Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects. ( Aaes-Jørgensen, T; Joffe, P; Larsen, FS; Pedersen, V; Ring-Larsen, H; Sidhu, J, 1998) |
| "Side effects such as myoclonus and tremor are rare when treating with selective serotonin reuptake inhibitors (SSRIs)." | 1.42 | [Myoclonus as a side effect to citalopram treatment in a patient with liver cirrhosis]. ( Bode, M; Forsberg-Gillving, M; Sindrup, SH, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forsberg-Gillving, M | 1 |
| Bode, M | 1 |
| Sindrup, SH | 1 |
| Schindler, EA | 1 |
| Guo, XM | 1 |
| Schrag, M | 1 |
| Ghoshal, S | 1 |
| Schilsky, ML | 1 |
| Beslow, LA | 1 |
| Joffe, P | 1 |
| Larsen, FS | 1 |
| Pedersen, V | 1 |
| Ring-Larsen, H | 1 |
| Aaes-Jørgensen, T | 1 |
| Sidhu, J | 1 |
1 trial available for citalopram and Liver Cirrhosis
| Article | Year |
|---|---|
Single-dose pharmacokinetics of citalopram in patients with moderate renal insufficiency or hepatic cirrhosis compared with healthy subjects.
Topics: Administration, Oral; Adolescent; Adult; Biological Availability; Citalopram; Female; Humans; Inject | 1998 |
2 other studies available for citalopram and Liver Cirrhosis
| Article | Year |
|---|---|
[Myoclonus as a side effect to citalopram treatment in a patient with liver cirrhosis].
Topics: Citalopram; Electroencephalography; Female; Humans; Liver Cirrhosis; Middle Aged; Myoclonus; Selecti | 2015 |
Neuropsychiatric Presentation of Wilson Disease in an Adolescent Male.
Topics: Adenosine Triphosphatases; Adolescent; Aggression; Antidepressive Agents; Antipsychotic Agents; Arip | 2016 |